LCP-AtorFen

· Veloxis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LCP-AtorFen, covering 2020-02-05 to 2020-03-24. Get the full timeline:

Most recent: Clinical Trial Update: 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia [Phase 2, Phase 3]